Colorectal cancer (CRC) is one of the most common malignancies worldwide. In spite of
various attempts to ameliorate outcome by escalating treatment, significant improvement is …

Background Cancer stem cell (CSC) epithelial cell adhesion molecule (Ep-CAM) is
frequently expressed in colorectal cancer (CRC). However, the clinical significance of Ep …

Background Epithelial cell adhesion molecule (EpCAM) is known to highly expression and
promotes cancer progression in many cancer types, including colorectal cancer. While …

Epithelial cell adhesion molecule (EpCAM) is known to be overexpressed in epithelial
cancers associated with enhanced malignant potential, particularly colorectal carcinoma …

Initially discovered as a dominant antigen on colon carcinomas, the epithelial cell adhesion
molecule (EpCAM) was considered a mere cell adhesion molecule and reliable surface …

Epithelial cell adhesion molecule (EpCAM) is highly expressed in colon cancers, but its role
in cancer progression remains to be elucidated. In this work, we found that the extracellular …

Background The crucial oncogenic role of cancer stem cells (CSCs) in tumor maintenance,
progression, drug resistance, and relapse has been clarified in different cancers, particularly …

Colorectal cancer is the most frequently occurring cancer in the Western world, with a
worldwide incidence of about 1 million, and with 70% to 80% of patients presenting initially …

Epithelial cell adhesion molecule (EpCAM) functions not only in physiological processes but
also participates in the development and progression of cancer. In recent decades …

The use of monoclonal antibodies as adjuvants to cancer chemotherapy has drawn
considerable interest in recent years, due to the success of several novel agents against a …